Moisés L. H.
- Country
- Spain
- Department
- 9752; Alergología
Research Overview
- A Phase 3b Long-term Efficacy and Safety Extension Study of Barzolvolimab in Participants with Chronic Spontaneous Urticaria
- Long-term safety of remibrutinib in patients with chronic spontaneous urticaria continuing from prior remibrutinib treatment trials
- A double-blind, randomized, placebo-controlled trial to evaluate the efficacy, pharmacokinetics and safety of remibrutinib (LOU064) for 24 weeks in adolescents from 12 to less than 18 years of age with chronic spontaneous urticaria inadequately controlled by H1-antihistamines followed by an optional open-label extension for up to another 3 years and an optional safety long-term treatment-free follow-up period for up to an additional 3 years.
Data & Insights
Has run more than one trial at 130 of 283 partner sites.
Specializations
Chronic Urticaria Management
This investigator specializes in treating various forms of chronic urticaria, with particular emphasis on both chronic spontaneous urticaria (CSU) and chronic inducible urticaria (CINDU). Their research explores innovative therapeutic approaches for patients who show inadequate response to conventional antihistamine treatments.
- Spontaneous Urticaria Therapeutics
- Inducible Urticaria Treatment
- Antihistamine-Refractory Cases
The investigator's work encompasses various urticaria subtypes including symptomatic dermographism, cold urticaria, and cholinergic urticaria.
Novel Therapeutic Agents
The investigator conducts research on emerging treatments including remibrutinib, ligelizumab, and barzolvolimab. Their work focuses on evaluating long-term efficacy and safety profiles of these therapeutic agents in various allergic conditions.
- Targeted Biological Therapies
- Long-term Treatment Outcomes
- Drug Safety Evaluation
Their research extends to both adult and adolescent patient populations, examining treatment responses across different age groups.
Allergic Conditions
Beyond urticaria, the investigator's expertise extends to broader allergic disorders, including food allergy. Their research evaluates therapeutic interventions for various allergic manifestations and their long-term management.
- Food Allergy Treatment
- Chronic Allergy Management
- Treatment Resistance Patterns
The focus includes developing treatment strategies for patients with complex allergic conditions requiring specialized therapeutic approaches.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.